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In our study, we examined the in vitro effects of P. marinus
serine protease treatment on the uptake and intracellular survival of V. vulnificus within oyster hemocytes by using a gentamicin internalization assay. The results showed that protease-treated hemocytes were initially slower to internalize V.
vulnificus than were untreated hemocytes and that the elimination of V. vulnificus by treated hemocytes was significantly
suppressed compared with that by similarly treated hemocytes
infected with a highly invasive strain of Salmonella enterica
serotype Enteritidis and a noninvasive Escherichia coli strain.
Our data suggest that P. marinus serine protease suppresses
the vibriocidal activity of oyster hemocytes to effectively eliminate V. vulnificus, potentially leading to conditions favoring
higher numbers of vibrios in oyster tissues.
An unencapsulated biotype 1 V. vulnificus strain, 4965T-1,
grown on thioproline-NaCl-glutamate agar (pH 8) for 18 h at
30°C, as described by Hanes et al. (5), was used in our experiments. Salmonella enterica serotype Enteritidis strain SE-3
and E. coli HB101 were used, respectively, as pathogenic, invasive and nonpathogenic, noninvasive control strains. Each of
these strains was grown on Trypticase soy agar (TSA) containing 1% NaCl for 18 h at 37°C. Although the mechanism(s)
whereby hemocytes kill V. vulnificus is unknown, we chose the
unencapsulated-phase variant of V. vulnificus in these experiments to maximize the killing effects. This decision is supported by evidence recently described by Harris-Young et al.
(6).
P. marinus-free oysters were obtained from Mook Sea Farm
(Damariscotta, Maine) and were maintained in flumes supplied with 1-m-pore-size-filtered York River water, 20 ppt
salinity. Oyster hemolymph was collected and viable hemocyte
counts were performed as described by La Peyre et al. (9).
Hemocytes (5 ⫻ 105 cells/ml) suspended in 1 ml of JLODRP-1 culture medium (9) were added to each well of four
24-well tissue culture plates, allowed to adhere for 30 min at
28°C, and then washed three times with artificial seawater
(ASW; 20 ppt salinity). Hemocytes in 12 wells of each 24-well
plate were coincubated with 1 ml of cell-free P. marinus ECP
in JL-ODRP medium containing 100 g of protein/ml (⬃3 U
of protease activity) for 1 h at room temperature. The ECP was
prepared and isolated according to the procedure described by

Vibrio vulnificus is associated with estuarine environments
and with various marine organisms (2, 7, 14) and has been
implicated as a cause of gastroenteritis, wound infections, and
primary septicemia in humans, with a mortality rate exceeding
50% (8, 19). In humans, serious illness most commonly occurs
when raw or undercooked seafood, such as shellfish, is ingested
or when open wounds are exposed to seawater carrying V.
vulnificus (8). V. vulnificus has been reported to persist at high
levels within Crassostrea virginica (eastern oyster) tissues and
to reproduce in hemolymph and other tissues during warm
weather (17, 18).
Most, if not all, C. virginica organisms found in mid-Atlantic
and Gulf Coast waters are heavily infected with Perkinsus marinus, an oyster pathogen responsible for severe oyster population losses throughout this region (3). All oysters from these
waters contain V. vulnificus (14). Concern about these two
oyster-associated microorganisms is increasing. Whether the
prevalence of these organisms in the eastern oyster is correlated cannot yet be determined.
Recently, however, some aspects of oyster mortalities induced by P. marinus have been unraveled (10, 11). Studies
reported by La Peyre (12) indicate that P. marinus produces a
serine protease (ECP) as a major virulence factor, which is
capable of digesting oyster connective tissues by degrading
extracellular matrix proteins. Moreover, Garreis et al. (4) provided evidence that the serine protease is also a potent immunosuppressant which can reduce oyster hemocyte motility and
lysosomal activity in oyster hemolymph. Other researchers
have found that the ability of oysters to resist infection with P.
marinus depends on the numbers and activities of hemocytes at
the time of infection (3). Reports by La Peyre et al. (9) of
declining levels of in vivo lysosomal activity and hemagglutination activity in heavily infected eastern oysters also support
these findings.
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The in vitro effects of the Perkinsus marinus serine protease on the intracellular survival of Vibrio vulnificus
in oyster hemocytes were examined by using a time-course gentamicin internalization assay. Results showed
that protease-treated hemocytes were initially slower to internalize V. vulnificus than untreated hemocytes.
After 1 h, the elimination of V. vulnificus by treated hemocytes was significantly suppressed compared with
hemocytes infected with invasive and noninvasive controls. Our data suggest that the serine protease produced
by P. marinus suppresses the vibriocidal activity of oyster hemocytes to effectively eliminate V. vulnificus,
potentially leading to conditions favoring higher numbers of vibrios in oyster tissues.
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TABLE 1. Recovery of V. vulnificus 4965T-1, S. enterica serotype Enteritidis strain SE-3, and E. coli HB01 from primary oyster hemocytes
treated with P. marinus ECP or left untreated
CFU/ml recovered from hemocytes (% recovery ⫾ SD) at indicated no. of min
Strain

Treated
0

4965T-1
SE-3
HB01

60

120
a

1,720 (0.04 ⫾ 0.04)
976.1 (0.38 ⫾ 0.7)
218.6 (0.08 ⫾ 0.09)

0

934 (0.02 ⫾ 0.03)
9,950 (0.44 ⫾ 0.2)
5 (0.0006 ⫾ 0.002)

a

3,700 (0.06 ⫾ 0.03)
3,120 (0.14 ⫾ 0.2)
3.3 (0.0005 ⫾ 0.001)

60

120

345 (0.008 ⫾ 0.005)
399.2 (0.17 ⫾ 0.04)
76 (0.033 ⫾ 0.02)

355 (0.007 ⫾ 0.007)
7,786 (0.34 ⫾ 0.01)
0.00

Statistically significant compared to analogous treated or untreated group, as determined by ANOVA.

La Peyre et al. (10). The remaining 12 wells received 1 ml of
fresh medium and were considered untreated controls.
Bacterial cell suspensions (108 CFU/ml) harvested in 0.9%
saline were diluted in the JL-ODRP-1 medium to give a multiplicity of infection of approximately five bacterial cells per
hemocyte. Inocula used to infect ECP-treated hemocytes were
prepared in fresh JL-ODRP-1 medium containing ECP. After
the bacterial inocula were added to the settled hemocytes, the
plates were incubated at 28°C for 0, 60, and 120 min. After
each incubation period, the hemocytes were washed with ASW
and incubated with 2 ml of JL-ODRP-01 medium containing
100 g of gentamicin/ml for 1 h at 28°C. The hemocytes were
again washed three times with ASW and lysed with 0.5 ml of
ice-cold sterile 0.05% Triton X-100 (Sigma Chemical Co., St.
Louis, Mo.) for 15 min at 28°C. Lysates were diluted 10-fold
with ASW, and 100-l aliquots of each dilution were spread
onto TSA plates containing 1% NaCl as the recovery medium.
After incubation at 28°C for 24 h, colonies were counted.
Recovery data percentages were calculated and analyzed as
described previously by using Student’s t test and one-factor
analysis of variance (ANOVA), followed by Dunns’ or Student-Newman-Keuls multiple comparisons of means when significant differences (P ⬍ 0.05) were found (5).
The percent recovery results of the experiments are summarized in Table 1. At 0 min of interaction, significantly more V.
vulnificus 4965-T1 cells were recovered in hemocytes not
treated with ECP than in hemocytes treated with ECP (⬃4.5
times, 3,700 CFU/ml versus 790 CFU/ml, P ⬍ 0.05). By 60 min
postchallenge, the average number of V. vulnificus cells recovered from untreated hemocytes decreased to 345 CFU/ml,
while the number of cells recovered from treated hemocytes
increased to 1,720 CFU/ml, a greater-than-fivefold difference
in recovered cells. The percent recovery for V. vulnificus internalized by treated hemocytes was significantly greater than that
recovered from untreated hemocytes (P ⬍ 0.05). Finally, by
120 min postchallenge, the average number of V. vulnificus
cells recovered from untreated hemocytes was 355 CFU/ml,
whereas the number of cells recovered from treated hemocytes
decreased from 1,720 to 934 CFU/ml. Even though the percent
recovery for V. vulnificus-internalized cells by treated hemocytes was approximately 2.5 times greater than that recovered
from untreated hemocytes, these numbers were not statistically
significant (Table 1).
Conversely, recovery of E. coli HB101 at 0 min of interaction
showed that significantly more (approximately 10-fold) E. coli
cells were recovered from treated hemocytes than from untreated hemocytes (35 versus 3.3 CFU/ml, P ⬍ 0.05). However,
the recovery of Enteritidis strain SE-3 from untreated hemocytes at this time was not significantly greater than that recovered from treated hemocytes, even though the number of
CFU/milliliter from the untreated hemocytes (3,120 versus 364
CFU/ml) was approximately 8 times greater. On average, by 60

min postchallenge, twice as many cells of Enteritidis and E. coli
were recovered from the treated hemocytes than from the
untreated hemocytes (976.1 strain SE-3 versus 218.6 E. coli
CFU/ml for the treated hemocytes and 399.2 strain SE-3 versus
76 E. coli CFU/ml for the untreated hemocytes). The percentage of recovery of both Enteritidis- and E. coli-internalized
cells from treated hemocytes, however, was not significantly
greater than the percentage recovered from untreated hemocytes. Finally, by 120 min postchallenge, 1.5 times as many cells
of Enteritidis were recovered from treated hemocytes as from
untreated hemocytes (9,950 versus 7,786 CFU/ml) for treated
and untreated hemocytes, respectively. The percent recovery
of Enteritidis-internalized cells from treated hemocytes was
not significantly greater than that recovered from untreated
hemocytes. No E. coli cells were recovered from the untreated
hemocyte group compared with 5 CFU/ml recovered from
treated hemocytes. This trend was not significant.
Severe P. marinus infections in the eastern oyster are accompanied by an overwhelming infectious dose, a high rate of
proliferation in host tissues, and a depressed oyster immune
response, all of which occur by as-yet-undefined mechanisms
(3, 12). It has been postulated that the protease may be responsible for the overwhelming immunosuppression culminating in the inability of oyster hemocytes to kill and degrade
intracellular P. marinus cells (4, 10). Taken together, our results demonstrate that the protease produced by P. marinus
induces a similar hemocytic immunosuppressive reaction
against V. vulnificus; protease-treated hemocytes were initially
slower to internalize V. vulnificus than untreated hemocytes,
but once V. vulnificus was internalized, the vibriocidal activities
of the treated hemocytes against it were suppressed compared
with those of the untreated hemocytes. These results correlate
well with the results reported by Garreis et al. (4), which
demonstrated an inhibition and reduction of antiprotozoan
activity in protease-treated hemocytes toward P. marinus. Similar inhibitory effects on neutrophil motility and neutrophil and
monocyte opsonization have been described for the Gp63 protease produced by Leishmania major (16). The internalization
and recovery of Enteritidis by hemocytes were unaffected by P.
marinus protease treatment, and the organism survived quite
well for over 2 h inside hemocytes. This lack of effect suggests
that Enteritidis is not readily killed by these cells. The process
of elimination of E. coli by the hemocytes was also unaffected
by treatment; however, the outcome did differ in that both
groups of hemocytes could effectively eliminate the organism.
The mechanism by which the Perkinsus serine protease immunomodulates oyster defense mechanisms is currently of great
interest and is being intensely studied (10).
Recovery of viable V. vulnificus was greater from proteasetreated hemocytes, affirming our hypothesis that in the feral
setting, higher numbers of V. vulnificus in oysters harvested
from waters warmer than 25°C may also be due to increased
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a

790 (0.02 ⫾ 0.1)
364 (0.016 ⫾ 0.02)
35 (0.005 ⫾ 0.003)a

Untreated

numbers of P. marinus (escalation of infection) and its immunosuppressive activities, controlled by the serine protease (5,
10, 11). In support of this hypothesis, Ordas et al. (15) reported
that the treatment of hemocytes obtained from both European
mussels and carpet clams with ECP isolated from another
Perkinsus species, P. atlanticus, had an inhibitory effect on the
phagocytic ability of hemocytes for Vibrio tapetis, the etiological agent of brown ring disease in clams (1). Additionally, La
Peyre and Volety reported a dose-dependent reduction in
vibriocidal activity in eastern oyster hemocytes treated with
ECP and infected with Vibrio parahaemolyticus (13). Together,
these data suggest that the serine protease expressed by these
two Perkinsus spp. can modulate the vibriocidal hemocytic response against multiple Vibrio spp. More importantly, these
studies stress the importance of verifying the health status of
the oyster (or clam) as a host and as a vehicle of transmission
before attempting to assess the levels of vibrios in these economically important marine species.
In conclusion, we describe an observation by which a secreted protease produced by the oyster pathogen P. marinus
significantly suppressed the innate vibriocidal ability of eastern
oyster hemocytes to eliminate V. vulnificus in vitro. This observation is significant for public health, especially for understanding how V. vulnificus persists in the oyster and can rise to
unsafe levels in edible oyster shell stock.
We thank undergraduate students Song Jin Kim and Furkhan Shinaishin for their help in performing these assays. We thank Anita
Green and Houston Garrett, at the FDA, for their help in preparing
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